These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 37516359

  • 1. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
    Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
    J Am Acad Dermatol; 2024 May; 90(5):885-908. PubMed ID: 37516359
    [Abstract] [Full Text] [Related]

  • 2. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
    Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
    J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
    [Abstract] [Full Text] [Related]

  • 3. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F, Asada H.
    Int J Mol Sci; 2021 Feb 21; 22(4):. PubMed ID: 33670052
    [Abstract] [Full Text] [Related]

  • 4. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
    Hama N, Abe R, Gibson A, Phillips EJ.
    J Allergy Clin Immunol Pract; 2022 May 21; 10(5):1155-1167.e5. PubMed ID: 35176506
    [Abstract] [Full Text] [Related]

  • 5. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T.
    J Dermatol; 2015 Mar 21; 42(3):276-82. PubMed ID: 25623158
    [Abstract] [Full Text] [Related]

  • 6. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL.
    Australas J Dermatol; 2014 Feb 21; 55(1):15-23. PubMed ID: 23866082
    [Abstract] [Full Text] [Related]

  • 7. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R, Mallal S, Ostrov D, Pompeu Y, Phillips E.
    J Allergy Clin Immunol Pract; 2014 Feb 21; 2(1):21-33. PubMed ID: 24565765
    [Abstract] [Full Text] [Related]

  • 8. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y, Azukizawa H, Asada H, Niihara H, Morita E, Yamauchi T, Mizukawa Y, Kusakabe Y, Numazawa S, Izumi M, Sueki H, Watanabe H.
    J Dermatol; 2019 Mar 21; 46(3):226-233. PubMed ID: 30663091
    [Abstract] [Full Text] [Related]

  • 9. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H, Saito K, Takayanagi Y, Okazaki T, Kashima K, Ishikawa K, Kai Y, Takeo N, Hatano Y, Okamoto O, Fujiwara S.
    J Dermatol; 2013 Feb 21; 40(2):118-22. PubMed ID: 23216243
    [Abstract] [Full Text] [Related]

  • 10. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
    Avancini J, Maragno L, Santi CG, Criado PR.
    Clin Exp Dermatol; 2015 Dec 21; 40(8):851-9. PubMed ID: 26271788
    [Abstract] [Full Text] [Related]

  • 11. Anti-tubercular therapy causing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
    Saxena P, Chadha D, Goyal R.
    J R Coll Physicians Edinb; 2020 Dec 21; 50(4):414-415. PubMed ID: 33469620
    [Abstract] [Full Text] [Related]

  • 12. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Takamiyagi S, Iriki H, Asahina Y, Furuichi Y, Funakoshi T, Ichikawa M, Mikami Y, Okita H, Sakiyama T, Inazumi T, Amagai M, Takahashi H.
    J Dermatol; 2022 Aug 21; 49(8):796-799. PubMed ID: 35502510
    [Abstract] [Full Text] [Related]

  • 13. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
    Del Pozzo-Magaña BR, Rieder MJ, Garcia-Bournissen F, Lazo-Langner A.
    Br J Clin Pharmacol; 2022 Sep 21; 88(9):4134-4141. PubMed ID: 35421262
    [Abstract] [Full Text] [Related]

  • 14. Alopecia universalis after drug reaction with eosinophilia and systemic symptoms (Dress).
    Hollingsworth P, Paci K, Evans M, Miedema J, Morrell DS.
    Pediatr Dermatol; 2020 Sep 21; 37(5):947-949. PubMed ID: 32524672
    [Abstract] [Full Text] [Related]

  • 15. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
    Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K.
    Allergol Int; 2016 Oct 21; 65(4):432-438. PubMed ID: 27134114
    [Abstract] [Full Text] [Related]

  • 16. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
    Shen Q, Wang Q, Zang H, Yu L, Cong X, Chen X, Chen L.
    BMC Endocr Disord; 2023 Jan 23; 23(1):22. PubMed ID: 36691013
    [Abstract] [Full Text] [Related]

  • 17. Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review.
    Awad A, Goh MS, Trubiano JA.
    J Allergy Clin Immunol Pract; 2023 Jun 23; 11(6):1856-1868. PubMed ID: 36893848
    [Abstract] [Full Text] [Related]

  • 18. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
    Maloney NJ, Rana J, Yang JJ, Zaba LC, Kwong BY.
    Support Care Cancer; 2022 Mar 23; 30(3):2839-2851. PubMed ID: 34546454
    [Abstract] [Full Text] [Related]

  • 19. Vancomycin-associated drug-induced hypersensitivity syndrome.
    Madigan LM, Fox LP.
    J Am Acad Dermatol; 2019 Jul 23; 81(1):123-128. PubMed ID: 30738120
    [Abstract] [Full Text] [Related]

  • 20. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S, Neema S, Vashisht D, Venugopal R, Sengupta P, Radhakrishnan S.
    Dermatol Ther; 2021 Jan 23; 34(1):e14670. PubMed ID: 33314590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.